HAEMATOLOGICA

Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort

PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells

Updates on the hematologic tumor microenvironment and its therapeutic targeting

How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies

Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation

Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis

NIPBL: a new player in myeloid cell differentiation

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma.

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract

Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population

Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort

New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.

Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.)

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease

Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?

Shear rate gradients promote a bi-phasic thrombus formation on weak adhesive proteins, such as fibrinogen in a VWF-dependent manner.

Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis.

Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells

Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation versus clearance

Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets

Recognition of hemophagocytic lymphohistiocytosis in sickle cell vaso-occlusive crises is a potentially lifesaving diagnosis

Standing at odds: mutated RAS and hematopoietic stem cells

CD27, CD201, FLT3, CD48, and CD150 cell surface staining identifies long-term mouse hematopoietic stem cells in immunodeficient non-obese diabetic severe combined immune deficient-derived strains

Co-inheritance of a-thalassemia dramatically decreases the risk of acute splenic sequestration in a large cohort of newborns with hemoglobin SC

Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.

The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs

Are we ready to use precision medicine in chronic myeloid leukemia practice?

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies

Ubiquitination is not omnipresent in myeloid leukemia

Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality

Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease

The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.

DNA damage on the DOCK in FLT3-ITD-driven acute myeloid leukemia

A tale of two genes: a new connection between NIPBL and NPM1 in acute myeloid leukemia

Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma

IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study